Are you living with Dermatomyositis (DM) or Polymyositis (PM)? You may be eligible to participate in a Phase II/III clinical research study evaluating an investigational treatment made from umbilical cord-lining stem cells.

This study is designed to evaluate the safety and effectiveness of allogeneic ULSC and its potential to improve disease severity and help participants reduce their reliance on steroid treatment.

If you are interested in participating and would like to learn more about eligibility and what the study involves, contact our research team today.